Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Despite New Phase 3 Trial24/7 Wall Street • 11/03/26
UPS's $5.4 Billion Dividend Bill Exceeded Its Free Cash Flow. Is the Payout at Risk?24/7 Wall Street • 11/03/26
Pfizer Beats Expectations in Q3 and Raises Its Guidance. Is the Stock Due for a Big Rally?The Motley Fool • 11/03/26
Pfizer Hikes Guidance On Solid Third Quarter, Names Company Vet As New CFOInvestors Business Daily • 11/03/26
$250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends24/7 Wall Street • 10/30/26
Regeneron Surges 12% as Sanofi Dupixent Windfall and Eylea HD Power Earnings Beat; Moderna Slides 2%, Merck Edges Higher, Pfizer Ticks Up24/7 Wall Street • 10/30/26